Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction

Don Hayes, Mark Galantowicz, Andrew R. Yates, Thomas J. Preston, Heidi M. Mansour, Patrick I. McConnell

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Extracorporeal membrane oxygenation (ECMO) is an established therapy for primary graft dysfunction (PGD) in adults after lung transplant, while venovenous (VV) ECMO is an evolving therapy that can bridge patients to lung transplantation. This report describes a case of relatively quick improvement of grade 3 PGD, based on the PaO2/FIO2 (P/F) ratio, in a 17-year-old patient with cystic fibrosis who was bridged to lung transplantation with ambulatory VV ECMO and then received support with VV ECMO as a protective strategy during the initial phases of PGD after lung transplantation.

Original languageEnglish (US)
Pages (from-to)382-385
Number of pages4
JournalJournal of Artificial Organs
Volume16
Issue number3
DOIs
StatePublished - Mar 19 2013

Keywords

  • Cystic fibrosis
  • Lung transplantation
  • Preventative
  • Primary graft dysfunction
  • Protective
  • Venovenous extracorporeal membrane oxygenation

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Venovenous ECMO as a bridge to lung transplant and a protective strategy for subsequent primary graft dysfunction'. Together they form a unique fingerprint.

  • Cite this